Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar:22 Suppl 2:587-622.
doi: 10.1111/ajt.16981.

OPTN/SRTR 2020 Annual Data Report: COVID

Affiliations

OPTN/SRTR 2020 Annual Data Report: COVID

J Miller et al. Am J Transplant. 2022 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure COV 1
Figure COV 1
Number of prevalent kidney candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Candidates listed at multiple centers are counted once per listing. Includes active and inactive candidates on the list any time during the month.
Figure COV 2
Figure COV 2
Number of new kidney candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. A new candidate is one who first joined the list during the given month, without having been listed in a previous month.
Figure COV 3
Figure COV 3
Deceased donor kidney transplant rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Transplant rates are computed as the number of deceased donor transplants per 100 patient-years of waiting in a given month. Individual listings are counted separately.
Figure COV 4
Figure COV 4
Living donor kidney transplant rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Transplant rates are computed as the number of living donor transplants per 100 patient-years of waiting in a given month. Individual listings are counted separately.
Figure COV 5
Figure COV 5
Number of kidney offers. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 6
Figure COV 6
Kidney offer acceptance rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 7
Figure COV 7
Kidney waiting list mortality rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Mortality rates are computed as the number of deaths per 100 patient-years of waiting in the given year. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 8
Figure COV 8
Kidney all-cause graft failure. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 9
Figure COV 9
Difference in risk adjusted kidney waiting list mortality hazard ratio before to after COVID-19 by OPO. Waiting list mortality hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 10
Figure COV 10
Difference in risk adjusted kidney transplant rate before to after COVID-19 by OPO. Transplant rate ratio is the difference in the OPO’s rate ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Individual listings are counted separately.
Figure COV 11
Figure COV 11
Difference in risk adjusted kidney all-cause graft failure hazard ratio before to after COVID-19 by OPO. Graft failure hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic.
Figure COV 12
Figure COV 12
Number of prevalent pancreas candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Candidates listed at multiple centers are counted once per listing. Includes active and inactive candidates on the list any time during the month.
Figure COV 13
Figure COV 13
Number of new pancreas candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. A new candidate is one who first joined the list during the given month, without having been listed in a previous month.
Figure COV 14
Figure COV 14
Deceased donor pancreas transplant rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Transplant rates are computed as the number of deceased donor transplants per 100 patient-years of waiting in a given month. Individual listings are counted separately.
Figure COV 15
Figure COV 15
Pancreas waiting list mortality rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Mortality rates are computed as the number of deaths per 100 patient-years of waiting in the given year. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 16
Figure COV 16
Pancreas all-cause graft failure. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 17
Figure COV 17
Difference in risk adjusted pancreas waiting list mortality hazard ratio before to after COVID-19 by OPO. Waiting list mortality hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 18
Figure COV 18
Difference in risk adjusted pancreas transplant rate before to after COVID-19 by OPO. Transplant rate ratio is the difference in the OPO’s rate ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Individual listings are counted separately.
Figure COV 19
Figure COV 19
Difference in risk adjusted pancreas all-cause graft failure hazard ratio before to after COVID-19 by OPO. Graft failure hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic.
Figure COV 20
Figure COV 20
Number of prevalent liver candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Candidates listed at multiple centers are counted once per listing. Includes active and inactive candidates on the list any time during the month.
Figure COV 21
Figure COV 21
Number of new liver candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. A new candidate is one who first joined the list during the given month, without having been listed in a previous month.
Figure COV 22
Figure COV 22
Deceased donor liver transplant rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Transplant rates are computed as the number of deceased donor transplants per 100 patient-years of waiting in a given month. Individual listings are counted separately.
Figure COV 23
Figure COV 23
Living donor liver transplant rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Transplant rates are computed as the number of living donor transplants per 100 patient-years of waiting in a given month. Individual listings are counted separately.
Figure COV 24
Figure COV 24
Number of liver offers. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 25
Figure COV 25
Liver offer acceptance rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 26
Figure COV 26
Liver waiting list mortality rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Mortality rates are computed as the number of deaths per 100 patient-years of waiting in the given year. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 27
Figure COV 27
Liver all-cause graft failure. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 28
Figure COV 28
Difference in risk adjusted liver waiting list mortality hazard ratio before to after COVID-19 by OPO. Waiting list mortality hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 29
Figure COV 29
Difference in risk adjusted liver transplant rate before to after COVID-19 by OPO. Transplant rate ratio is the difference in the OPO’s rate ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Individual listings are counted separately.
Figure COV 30
Figure COV 30
Difference in risk adjusted liver all-cause graft failure hazard ratio before to after COVID-19 by OPO. Graft failure hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic.
Figure COV 31
Figure COV 31
Number of prevalent intestine candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Candidates listed at multiple centers are counted once per listing. Includes active and inactive candidates on the list any time during the month.
Figure COV 32
Figure COV 32
Number of new intestine candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. A new candidate is one who first joined the list during the given month, without having been listed in a previous month.
Figure COV 33
Figure COV 33
Deceased donor intestine transplant rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Transplant rates are computed as the number of deceased donor transplants per 100 patient-years of waiting in a given month. Individual listings are counted separately.
Figure COV 34
Figure COV 34
Intestine waiting list mortality rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Mortality rates are computed as the number of deaths per 100 patient-years of waiting in the given year. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 35
Figure COV 35
Intestine all-cause graft failure. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 36
Figure COV 36
Difference in risk adjusted intestine transplant rate before to after COVID-19 by OPO. Transplant rate ratio is the difference in the OPO’s rate ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Individual listings are counted separately.
Figure COV 37
Figure COV 37
Difference in risk adjusted intestine all-cause graft failure hazard ratio before to after COVID-19 by OPO. Graft failure hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic.
Figure COV 38
Figure COV 38
Number of prevalent heart candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Candidates listed at multiple centers are counted once per listing. Includes active and inactive candidates on the list any time during the month.
Figure COV 39
Figure COV 39
Number of new heart candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. A new candidate is one who first joined the list during the given month, without having been listed in a previous month.
Figure COV 40
Figure COV 40
Deceased donor heart transplant rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Transplant rates are computed as the number of deceased donor transplants per 100 patient-years of waiting in a given month. Individual listings are counted separately.
Figure COV 41
Figure COV 41
Number of heart offers. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 42
Figure COV 42
Heart offer acceptance rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 43
Figure COV 43
Heart waiting list mortality rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Mortality rates are computed as the number of deaths per 100 patient-years of waiting in the given year. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 44
Figure COV 44
Heart all-cause graft failure. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 45
Figure COV 45
Difference in risk adjusted heart waiting list mortality hazard ratio before to after COVID-19 by OPO. Waiting list mortality hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 46
Figure COV 46
Difference in risk adjusted heart transplant rate before to after COVID-19 by OPO. Transplant rate ratio is the difference in the OPO’s rate ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Individual listings are counted separately.
Figure COV 47
Figure COV 47
Difference in risk adjusted heart all-cause graft failure hazard ratio before to after COVID-19 by OPO. Graft failure hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic.
Figure COV 48
Figure COV 48
Number of prevalent lung candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Candidates listed at multiple centers are counted once per listing. Includes active and inactive candidates on the list any time during the month.
Figure COV 49
Figure COV 49
Number of new lung candidates. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. A new candidate is one who first joined the list during the given month, without having been listed in a previous month.
Figure COV 50
Figure COV 50
Deceased donor lung transplant rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Transplant rates are computed as the number of deceased donor transplants per 100 patient-years of waiting in a given month. Individual listings are counted separately.
Figure COV 51
Figure COV 51
Number of lung offers. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 52
Figure COV 52
Lung offer acceptance rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 53
Figure COV 53
Lung waiting list mortality rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency. Mortality rates are computed as the number of deaths per 100 patient-years of waiting in the given year. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 54
Figure COV 54
Lung all-cause graft failure. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.
Figure COV 55
Figure COV 55
Difference in risk adjusted lung waiting list mortality hazard ratio before to after COVID-19 by OPO. Waiting list mortality hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Waiting time is censored at transplant, death, transfer to another program, removal because of improved condition, or end of cohort. Individual listings are counted separately.
Figure COV 56
Figure COV 56
Difference in risk adjusted lung transplant rate before to after COVID-19 by OPO. Transplant rate ratio is the difference in the OPO’s rate ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic. Individual listings are counted separately.
Figure COV 57
Figure COV 57
Difference in risk adjusted lung all-cause graft failure hazard ratio before to after COVID-19 by OPO. Graft failure hazard ratio is the difference in the OPO’s hazard ratio compared to the nation as a whole in the 12 months after the onset of the COVID-19 pandemic as compared to the 12 months before the onset of the pandemic.
Figure COV 58
Figure COV 58
Eligible deaths referral rate. Month 0 begins March 13, 2020, the date of declaration of the National Emergency.

References

    1. Miller J, Wey A, Musgrove D, et al. Mortality among solid organ waitlist candidates during COVID-19 in the United States. Am J Transplant. 2021;(November 2020):1–7. 10.1111/ajt.16550. - DOI - PMC - PubMed
    1. Boyarsky BJ, Werbel WA, Durand CM, et al. Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. 2020;20(11):3131–3139. doi: 10.1111/ajt.16167. - DOI - PMC - PubMed
    1. Cholankeril G, Podboy A, Alshuwaykh OS, et al. Early impact of COVID-19 on solid organ transplantation in the United States. Transplantation. 2020;104(11):2221–2224. doi: 10.1097/TP.0000000000003391. - DOI - PMC - PubMed
    1. Khairallah P, Aggarwal N, Awan AA, et al. The impact of COVID-19 on kidney transplantation and the kidney transplant recipient - one year into the pandemic. Transpl Int. Published online 2021:1–10. 10.1111/tri.13840 - DOI - PMC - PubMed